[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Chugai Pharm ADR (CHGCY)

Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chugai Pharm ADR Nihonbashi Mitsui Tower 15th Floor 2-1-1 Nihonbashi-Muromachi 2-chome Chuo-ku Tokyo M0 103-8324 JPN

www.chugai-pharm.co.jp Employees: 7,778 P: 813-3281-6611

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.

Key Statistics

Overview:

Market Capitalization, $K 77,282,704
Enterprise Value, $K 74,424,472
Shares Outstanding, K 3,291,427
Float, K 3,291,427
% Float 100.00%
Short Interest, K 37
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.09
% of Institutional Shareholders 0.01%

Financials:

Annual Sales, $ 8,428 M
Annual Net Income, $ 2,908 M
Last Quarter Sales, $ 2,059 M
Last Quarter Net Income, $ 738,680 K
EBIT, $ 1,016 M
EBITDA, $ 1,234 M

Growth:

1-Year Return -4.12%
3-Year Return 62.11%
5-Year Return 22.72%
5-Year Revenue Growth 13.94%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.22 on 04/24/26
Next Earnings Date 07/23/26 [--]
Earnings Per Share ttm 0.90
EPS Growth vs. Prev Qtr -12.00%
EPS Growth vs. Prev Year 15.79%
Annual Dividend & Yield (Paid) 0.31 (1.32%)
Annual Dividend & Yield (Fwd) 0.62 (2.67%)
Most Recent Dividend 0.288 on 06/26/25
Next Ex-Dividends Date 12/29/25
Dividend Payable Date 09/22/14
Dividend Payout Ratio 65.74%
Most Recent Split 12-1 on 07/06/20

CHGCY Ratios

Ratio
Price/Earnings ttm 25.84
Price/Earnings forward 23.74
Price/Earnings to Growth N/A
Return-on-Equity % 22.90%
Return-on-Assets % 19.45%
Profit Margin % 34.50%
Debt/Equity 0.00
Price/Sales 9.10
Price/Cash Flow 24.53
Price/Book 6.27
Book Value/Share 3.71
Interest Coverage 2,882.52
60-Month Beta 0.59

CHGCY Dividends

Date Value
06/26/25 $0.2880
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.